SMTL ID : 4fny.1

Crystal structure of the R1275Q anaplastic lymphoma kinase catalytic domain in complex with a benzoxazole inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

monomer

Ligands

1 x I3K: N-(4-chlorophenyl)-5-[(6,7-dimethoxyquinolin-4-yl)oxy]-1,3-benzoxazol-2-amine(Non-covalent)

I3K.1: 18 residues within 4Å: Chain A: L.39, V.47, A.65, E.84, I.88, F.91, L.113, E.114, L.115, M.116, G.119, F.162, H.164, L.173, I.185, G.186, D.187, F.188 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.47, A:A.65, A:I.88, A:I.88, A:L.113, A:L.173, A:D.187, A:F.188 Hydrogen bonds: A:E.84, A:M.116, A:D.187

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Epstein, L.F. et al., The R1275Q Neuroblastoma Mutant and Certain ATP-competitive Inhibitors Stabilize Alternative Activation Loop Conformations of Anaplastic Lymphoma Kinase. J.Biol.Chem. (2012)

Release Date

2012-08-29

Peptides

ALK tyrosine kinase receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK tyrosine kinase receptor

Related Entries With Identical Sequence